Biomerica Inc, a global provider of advanced medical products, recently reported their financial results for the second quarter of 2024. The company showed a loss of $-0.09 per share, which was an improvement from the loss of $-0.12 per share compared to the same period last year. However, there was a slight increase in shortfall from the previous reporting season, going from $-0.07 per share.Despite the losses, Biomerica Inc saw a revenue growth of 5.742% to $1.57 million in the second quarter of 2024, up from $1.48 million in the same period last year. However, there was a sequential revenue deterioration of -8.523% from the previous quarter. The companyns business surge was short of 11.12% compared to the second qu https://csimarket.com/stocks/news.php?code=BMRA&date=2024-02-17221244&utm_source=dlvr.it&utm_medium=tumblr
